Search
News
UCSF Health Reaches 15,000 Robotic Surgeries
UCSF Health has the busiest robotic surgery program in the UC health system and is the leading academic medical institution for robotic surgeries in the western U.S.
News
Improving Prediction of Advanced Breast Cancer Among Women of Different Races and Ethnicities
While regular screenings may decrease the chance of diagnosis of advanced breast cancer in some women and lead to a 20% reduction in breast cancer mortality, other women will be diagnosed with advanced breast cancer despite screening at regular intervals.
Document
UCSF Ranked #10 for Cancer Care | Clinical Trials Update
We are pleased to announce that UCSF Medical Center has been recognized as the best hospital in Northern California for cancer care — and among the top 10 cancer programs nationally — by U.S. News & World Report’s 2020-21 survey of Best Hospitals.
News
Enhancing Care for Thoracic Oncology Surgery Patients
Building on a decades-long reputation for innovation in thoracic surgery, UC San Francisco’s Thoracic Surgery and Oncology Clinic has improved the overall experience for patients undergoing lung and esophageal cancer treatment while continuing to maintain strong outcomes.
News
Patients With Detectable PSA After Radical Prostatectomy Have Good Long-Term Outcomes, UCSF Researchers Find
Patients with a detectable prostate-specific antigen (PSA) after radical prostatectomy (RP) may have excellent long-term outcomes, according to two retrospective studies conducted by UCSF researchers.
News
Renowned Expert to Lead UCSF’s Hematology and Oncology Division
Krishna Komanduri, MD, an international leader in hematology-oncology, transplantation and cellular immunotherapy, is the new chief of UCSF’s Division of Hematology and Oncology.
Video
Get Current on COVID: The Evidence on Vaccine Efficacy and Strategies for Immunocompromised Patients
A panel of experts answers all the current questions on breakthrough infections, who needs boosters, whether to keep recommending masks, and the future of variants, with a spotlight on meeting the needs of the immunocompromised, such as organ transplant recipients and cancer patients. Bonus: what to know about molnupiravir to treat COVID-19.
Video
Adrenal Tumors and Posterior Retroperitoneoscopic Adrenalectomy (PRA): A Case Study
Sanziana Roman, MD, an endocrine surgeon, discusses a patient’s treatment for a tumor in the retroperitoneum, near the adrenal gland.
News
New Study Looks at Why Cancer Treatments Cause Heart Damage
Teams from UC San Francisco and Stanford University will study why certain cancer treatments cause cardiotoxicities for some patients but not for others.
News
Felix Feng, Giant in the Field of Prostate Cancer, Dies at 48
“Felix Feng was an exceptional scientist – a once-in-a-generation scientist – and his staggering intellect and scientific insights led to his remarkable scientific accomplishments,"
News
A Novel Approach Towards a Vaccine for Relapsing Acute Myeloid Leukemia: Q&A with Dr. Karin Gaensler
There is a major clinical unmet need for effective and safe therapies to increase progression-free and overall survival in older individuals with leukemia whose prognosis is grim.
News
Engineered Receptors Help the Immune System Home in on Cancer
Most cancer treatments – from chemotherapies to engineered immune cells – have a host of side effects, in large part because they affect healthy cells in the body at the same time as targeting tumor cells
Video
Breast Changes: Managing Lumps, Pain, Discharge and Other Common Concerns
Breast anatomy is complex, and everything from aging to implants can make exams tricky. Breast surgeon Shoko Emily Abe, MD, FACS, offers help with working up common issues that are often benign yet may require treatment or follow-up.
News
Brachytherapy Improves Outcomes for Cervical Cancer Patients
Patients with locally advanced cervical cancer who receive chemoradiation therapy and brachytherapy and complete treatment within eight weeks have a superior overall survival rate compared to those who don’t receive this treatment, according to a UCSF study.
News
First-line Pembrolizumab Plus Chemotherapy May Benefit Patients with Advanced Biliary Tract Cancers
The addition of pembrolizumab (Keytruda) to gemcitabine and cisplatin improved overall survival in patients with untreated metastatic or unresectable biliary tract cancer, according to results from the phase III KEYNOTE-966 clinical trial.
News
Response to Cancer Immunotherapy May Be Affected by Genes We Carry from Birth
A new study finds that inherited genetic variation plays a role in who is likely to benefit from checkpoint inhibitors, which release the immune system’s brakes so it can attack cancer.
News
Prostate Cancer Study: More Health Benefits from Plant-Based Diet
Men with prostate cancer could significantly reduce the chances of the disease worsening by eating more fruits, vegetables, nuts and olive oil, according to new research by UC San Francisco.
Document
Cancer Services Referral Directory
One of the primary objectives at the UCSF Helen Diller Family Comprehensive Cancer Center is to be a partner in care, supporting patients’ treatments and providing physicians with efficient access to our services.
Video
Personalized Therapy for Early-Stage Lung Cancer at UCSF
Follow the journey of a UCSF patient with early-stage, high-risk lung cancer, from history to treatment and prognosis, including how surgeons chose to do a robotic assisted VATS lobectomy and an analysis of how well chemo is likely to work for her.
News
Rethinking How Cancer Cells Evade Targeted Therapy
Glioblastomas (GBMs) are incurable brain tumors with a prognosis of about one-and-a half years on average. They are highly resistant to treatment and have defied all attempts at precision therapy.
News
Can Gene Expression Predict if a Brain Tumor Is Likely to Grow Back?
Screening tumors using this new approach could change the course of treatment for nearly 1 in 3 people with meningioma, the most common form of brain tumor diagnosed in 42,000 Americans each year.
Document
Pancreas Center
Novel therapeutics and state-of-the-art surgical techniques combined with an array of support services for patients
News
Novel Immunotherapy Combination Destroys Colorectal Liver Metastases
UCSF researchers disrupt tumor immune environment with LIGHT/anti-CTLA-4 therapy in preclinical models.
News
Killing Pancreatic Cancer with T Cells that Turbocharge Themselves
Novel Immunotherapy Pumps Out Cancer-Killing Cytokines Only Inside the Tumor
